Jubilant Pharmova Limited (JUBLPHARMA.NS)
INR 906.95
(1.0%)
INR 906.95
(1.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 14.45 Billion INR | -64.91% |
| 2022 | 41.19 Billion INR | 19.47% |
| 2021 | 34.47 Billion INR | 11.51% |
| 2020 | 30.91 Billion INR | -23.36% |
| 2019 | 40.34 Billion INR | 6.34% |
| 2018 | 37.93 Billion INR | 19.53% |
| 2017 | 31.73 Billion INR | 30.08% |
| 2016 | 24.39 Billion INR | 2.14% |
| 2015 | 23.88 Billion INR | -2.71% |
| 2014 | 24.55 Billion INR | 6.45% |
| 2013 | 23.06 Billion INR | 1.03% |
| 2012 | 22.83 Billion INR | 64.95% |
| 2011 | 13.84 Billion INR | -18.07% |
| 2010 | 16.89 Billion INR | 2419.75% |
| 2009 | 670.48 Million INR | -94.95% |
| 2008 | 13.28 Billion INR | 60.24% |
| 2007 | 8.29 Billion INR | 36.95% |
| 2006 | 6.05 Billion INR | 1813.55% |
| 2005 | 316.41 Million INR | -91.33% |
| 2004 | 3.64 Billion INR | 25.69% |
| 2003 | 2.9 Billion INR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 4.6 Billion INR | 13.86% |
| 2024 Q2 | 9.89 Billion INR | -25.41% |
| 2023 Q1 | 9.66 Billion INR | -18.31% |
| 2023 Q3 | 10.05 Billion INR | 4.32% |
| 2023 Q2 | 9.64 Billion INR | -0.24% |
| 2023 Q4 | 4.04 Billion INR | -59.76% |
| 2023 FY | 14.45 Billion INR | -64.91% |
| 2022 Q2 | 9.76 Billion INR | 2.22% |
| 2022 FY | 41.19 Billion INR | 19.47% |
| 2022 Q4 | 11.83 Billion INR | 17.89% |
| 2022 Q3 | 10.03 Billion INR | 2.73% |
| 2022 Q1 | 9.55 Billion INR | 58.2% |
| 2021 FY | 34.47 Billion INR | 11.51% |
| 2021 Q4 | 6.04 Billion INR | -34.57% |
| 2021 Q1 | 9.65 Billion INR | 64.88% |
| 2021 Q3 | 9.23 Billion INR | -3.3% |
| 2021 Q2 | 9.54 Billion INR | -1.13% |
| 2020 Q2 | 11.05 Billion INR | 6.74% |
| 2020 FY | 30.91 Billion INR | -23.36% |
| 2020 Q4 | 5.85 Billion INR | -34.08% |
| 2020 Q1 | 10.35 Billion INR | 39.19% |
| 2020 Q3 | 8.88 Billion INR | -19.63% |
| 2019 Q1 | 10.65 Billion INR | 32.68% |
| 2019 FY | 40.34 Billion INR | 6.34% |
| 2019 Q2 | 11.11 Billion INR | 4.32% |
| 2019 Q3 | 11.12 Billion INR | 0.09% |
| 2019 Q4 | 7.44 Billion INR | -33.13% |
| 2018 Q1 | 9 Billion INR | -14.8% |
| 2018 Q4 | 8.03 Billion INR | -25.8% |
| 2018 FY | 37.93 Billion INR | 19.53% |
| 2018 Q3 | 10.82 Billion INR | 7.41% |
| 2018 Q2 | 10.07 Billion INR | 11.91% |
| 2017 Q1 | 7.07 Billion INR | -9.04% |
| 2017 FY | 31.73 Billion INR | 30.08% |
| 2017 Q4 | 10.56 Billion INR | 11.72% |
| 2017 Q3 | 9.45 Billion INR | 17.19% |
| 2017 Q2 | 8.07 Billion INR | 14.07% |
| 2016 Q3 | 7.04 Billion INR | 7.21% |
| 2016 Q4 | 7.77 Billion INR | 10.45% |
| 2016 Q2 | 6.56 Billion INR | 0.38% |
| 2016 FY | 24.39 Billion INR | 2.14% |
| 2016 Q1 | 6.54 Billion INR | -12.76% |
| 2015 FY | 23.88 Billion INR | -2.71% |
| 2015 Q1 | 6.49 Billion INR | 75.47% |
| 2015 Q2 | 6.82 Billion INR | 5.09% |
| 2015 Q3 | 6.62 Billion INR | -3.04% |
| 2015 Q4 | 7.5 Billion INR | 13.31% |
| 2014 Q3 | 7.11 Billion INR | 2.08% |
| 2014 Q4 | 3.7 Billion INR | -47.93% |
| 2014 Q2 | 6.96 Billion INR | 2.85% |
| 2014 FY | 24.55 Billion INR | 6.45% |
| 2014 Q1 | 6.77 Billion INR | 79.43% |
| 2013 FY | 23.06 Billion INR | 1.03% |
| 2013 Q4 | 3.77 Billion INR | -43.34% |
| 2013 Q3 | 6.66 Billion INR | 0.82% |
| 2013 Q2 | 6.6 Billion INR | 28.28% |
| 2013 Q1 | 5.15 Billion INR | -14.44% |
| 2012 Q3 | 5.71 Billion INR | 4.03% |
| 2012 FY | 22.83 Billion INR | 64.95% |
| 2012 Q4 | 6.02 Billion INR | 5.36% |
| 2012 Q2 | 5.49 Billion INR | 18.84% |
| 2012 Q1 | 4.62 Billion INR | 744.23% |
| 2011 FY | 13.84 Billion INR | -18.07% |
| 2011 Q3 | 5.38 Billion INR | 0.0% |
| 2011 Q4 | -717.46 Million INR | -113.33% |
| 2010 FY | 16.89 Billion INR | 2419.75% |
| 2009 FY | 670.48 Million INR | -94.95% |
| 2008 FY | 13.28 Billion INR | 60.24% |
| 2007 FY | 8.29 Billion INR | 36.95% |
| 2006 FY | 6.05 Billion INR | 1813.55% |
| 2005 FY | 316.41 Million INR | -91.33% |
| 2004 FY | 3.64 Billion INR | 25.69% |
| 2003 FY | 2.9 Billion INR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Amrutanjan Health Care Limited | 2.09 Billion INR | -590.246% |
| Biofil Chemicals and Pharmaceuticals Limited | 6.82 Million INR | -211835.484% |
| Caplin Point Laboratories Limited | 2.17 Billion INR | -564.705% |
| FDC Limited | 3.49 Billion INR | -313.0% |
| Gufic Biosciences Limited | 1.18 Billion INR | -1118.113% |
| Hikal Limited | 4.46 Billion INR | -223.805% |
| Ind-Swift Laboratories Limited | 2.12 Billion INR | -580.45% |
| IOL Chemicals and Pharmaceuticals Limited | 2.2 Billion INR | -556.701% |
| Kilitch Drugs (India) Limited | 412.42 Million INR | -3404.62% |
| Medico Remedies Limited | 59.67 Million INR | -24121.198% |
| Nectar Lifesciences Limited | 932.7 Million INR | -1449.694% |
| Par Drugs and Chemicals Limited | 58.28 Million INR | -24697.549% |
| RPG Life Sciences Limited | 1.63 Billion INR | -783.766% |
| Sequent Scientific Limited | 2.9 Billion INR | -398.103% |
| Shilpa Medicare Limited | 3.33 Billion INR | -333.51% |
| Sigachi Industries Limited | 579.88 Million INR | -2392.555% |
| Themis Medicare Limited | 1.12 Billion INR | -1183.889% |
| Unichem Laboratories Limited | 6.72 Billion INR | -114.902% |
| Venus Remedies Limited | 1.91 Billion INR | -654.272% |
| Wanbury Limited | 978.96 Million INR | -1376.456% |
| ZIM Laboratories Limited | 1.01 Billion INR | -1326.769% |
| Lupin Limited | 125.09 Billion INR | 88.446% |
| Innova Captab Limited | 931.03 Million INR | -1452.474% |
| Ind-Swift Limited | 946.56 Million INR | -1426.992% |
| Bajaj HealthCare Limited | 985.34 Million INR | -1366.897% |
| Aurobindo Pharma Limited | 55.65 Billion INR | 74.031% |
| Solara Active Pharma Sciences Limited | 2.55 Billion INR | -465.914% |
| AstraZeneca Pharma India Limited | 2.47 Billion INR | -484.354% |
| Mangalam Drugs & Organics Limited | 162.22 Million INR | -8809.683% |
| Morepen Laboratories Limited | 1.98 Billion INR | -627.264% |
| Laurus Labs Limited | 11.9 Billion INR | -21.362% |
| Aarti Drugs Limited | 1.16 Billion INR | -1138.052% |
| Glenmark Life Sciences Limited | 11.64 Billion INR | -24.168% |
| Alembic Limited | 872.45 Million INR | -1556.699% |
| Alembic Pharmaceuticals Limited | 15.86 Billion INR | 8.921% |
| Glenmark Pharmaceuticals Limited | 46.95 Billion INR | 69.216% |
| Vaishali Pharma Limited | 84.02 Million INR | -17101.204% |
| Aarti Pharmalabs Limited | 3.07 Billion INR | -370.141% |
| Jagsonpal Pharmaceuticals Limited | 438.55 Million INR | -3195.861% |
| Eris Lifesciences Limited | 4.94 Billion INR | -192.417% |
| Windlas Biotech Limited | 1 Billion INR | -1336.051% |
| Sun Pharmaceutical Industries Limited | 154.18 Billion INR | 90.625% |
| Lincoln Pharmaceuticals Limited | 1.07 Billion INR | -1245.577% |
| Orchid Pharma Limited | 800.77 Million INR | -1705.01% |
| Albert David Limited | 1.02 Billion INR | -1308.57% |
| Hester Biosciences Limited | 908.84 Million INR | -1490.379% |
| Sakar Healthcare Limited | 204.07 Million INR | -6982.551% |
| Suven Pharmaceuticals Limited | 1.4 Billion INR | -930.376% |
| Procter & Gamble Health Limited | 2.99 Billion INR | -382.54% |
| Divi's Laboratories Limited | 14.17 Billion INR | -2.004% |
| Mankind Pharma Limited | 29.27 Billion INR | 50.623% |
| Neuland Laboratories Limited | 2.92 Billion INR | -393.353% |
| J. B. Chemicals & Pharmaceuticals Limited | 14.79 Billion INR | 2.289% |
| Zydus Lifesciences Limited | 125.21 Billion INR | 88.456% |
| Wockhardt Limited | 8.48 Billion INR | -70.448% |
| Bal Pharma Limited | 555.62 Million INR | -2501.39% |
| Dr. Reddy's Laboratories Limited | 95.87 Billion INR | 84.925% |
| Bliss GVS Pharma Limited | 1.41 Billion INR | -918.445% |
| Alkem Laboratories Limited | 32.83 Billion INR | 55.98% |
| Valiant Laboratories Limited | 138.02 Million INR | -10371.712% |
| Ajanta Pharma Limited | 30.46 Billion INR | 52.552% |
| Bafna Pharmaceuticals Limited | 455.58 Million INR | -3072.624% |
| Aarey Drugs & Pharmaceuticals Limited | 14.21 Million INR | -101595.631% |
| Granules India Limited | 10.31 Billion INR | -40.156% |
| Medicamen Biotech Limited | 335.16 Million INR | -4212.477% |
| Ipca Laboratories Limited | 18.98 Billion INR | 23.877% |
| Brooks Laboratories Limited | 51.18 Million INR | -28141.501% |
| Syncom Formulations (India) Limited | 345.63 Million INR | -4081.892% |
| Piramal Enterprises Limited | 63.65 Billion INR | 77.292% |
| Torrent Pharmaceuticals Limited | 21.42 Billion INR | 32.528% |
| NATCO Pharma Limited | 10.05 Billion INR | -43.707% |
| Suven Life Sciences Limited | 109.75 Million INR | -13069.932% |
| Krebs Biochemicals & Industries Limited | 46.15 Million INR | -31215.539% |
| Strides Pharma Science Limited | 9.16 Billion INR | -57.755% |
| Indoco Remedies Limited | 12.06 Billion INR | -19.839% |
| Alpa Laboratories Limited | 127.38 Million INR | -11247.15% |
| Lasa Supergenerics Limited | 291.17 Million INR | -4864.042% |
| Sun Pharma Advanced Research Company Limited | 3.07 Billion INR | -369.774% |